Search Result "P2Y12 inhibitor monotherapy."
New Approaches in P2Y12 Receptor Blocker Drugs Use
Ebook: Frontiers in Cardiovascular Drug Discovery
Volume: 6 Year: 2022
Author(s):
Doi: 10.2174/97898150369091220600006
Is there Sex-related Outcome Difference According to oral P2Y12 Inhibitors in Patients with Acute Coronary Syndromes? A Systematic Review and Meta-Analysis of 107,126 Patients
Journal: Current Vascular Pharmacology
Volume: 17 Issue: 2 Year: 2019 Page: 191-203
Author(s): Oliver Brown,Jennifer Rossington,Gill Louise Buchanan,Giuseppe Patti,Angela Hoye
Emerging P2Y12 Receptor Antagonists: Role in Coronary Artery Disease
Journal: Current Vascular Pharmacology
Volume: 8 Issue: 1 Year: 2010 Page: 93-101
Author(s): Carrie S. Oliphant, J. Bradford Doby, Crystal L. Blade, Kanak Das, Debabrata Mukherjee, Pranab Das
Advances in Antiplatelet Therapy for Stroke Prevention: the New P2Y12 antagonists
Journal: Current Drug Targets
Volume: 11 Issue: 3 Year: 2010 Page: 380-391
Author(s): A. Giossi, A. Pezzini, E. Del Zotto, I. Volonghi, P. Costa, D. Ferrari, A. Padovani
Prolonging Ticagrelor Beyond a Year of Acute Coronary Syndrome: Worth or Harmful?
Journal: Current Vascular Pharmacology
Volume: 16 Issue: 5 Year: 2018 Page: 446-450
Author(s): Daniel Aradi,Dome Dezsi,Gabor Veress,Bela Merkely
Efficacy and Safety Outcomes of Short Duration Antiplatelet Therapywith Early Cessation of Aspirin Post Percutaneous Coronary Intervention:A Systematic Review and Meta-analysis
Journal: Current Cardiology Reviews
Volume: 17 Issue: 6 Year: 2021 Page: 10-20
Author(s): Firas R. AL-Obaidi,Hayley A. Hutchings,Andy S.C. Yong,Hasan Al-Farhan,Mohammed H. Al-Ali,Tahsin Al-Kinani,Mohammed Al-Myahi,Hussein Al-Kenzawi,Nazar Al-Sudani
Oral Antiplatelet Therapy for Acute Coronary Syndromes: Aspirin, P2Y12 Inhibition and Thrombin Receptor Antagonists
Journal: Current Drug Targets
Volume: 12 Issue: 1 Year: 2011 Page: 1805-1812
Author(s): Alison L. Bailey, Charles L. Campbell
Comparative Efficacy and Safety of Duration of Dual Antiplatelet Therapy in Patients with CAD Undergoing Drug-eluting Stent Implantation: A Systematic Review and Network Meta-analysis
Journal: Current Pharmaceutical Design
Volume: 26 Issue: 44 Year: 2020 Page: 5739-5745
Author(s): Jieqiong Guan,Wenjing Song,Pan He,Siyu Fan,Hong Zhi,Lina Wang
Use of Alternative Antiplatelet Agents for Clopidogrel Hypersensitivity
Journal: Current Vascular Pharmacology
Volume: 17 Issue: 2 Year: 2019 Page: 127-132
Author(s): Ayesha Ather,Craig J. Beavers
Aspirin Hypersensitivity in Patients Undergoing Percutaneous Coronary Intervention. What Should We be Doing?
Journal: Current Vascular Pharmacology
Volume: 17 Issue: 4 Year: 2019 Page: 326-331
Author(s): George Kassimis,Tushar Raina,Dimitrios Alexopoulos